AbbVie Inc.
ABBV
$236.19
$2.331.00%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 8,354.55% | -88.08% | -31.53% | -6.06% | -102.68% |
| Total Depreciation and Amortization | -5.47% | -0.77% | -3.80% | -1.69% | 1.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -64.81% | 233.21% | 26.72% | 154.29% | 279.96% |
| Change in Net Operating Assets | -19.14% | 67.07% | 83.38% | -1,144.53% | -189.62% |
| Cash from Operations | -25.96% | 28.95% | 126.90% | -59.53% | 48.29% |
| Capital Expenditure | -13.06% | -53.01% | -11.62% | -21.76% | -41.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 35.21% | 67.01% | -11.51% | 94.27% | -224.05% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -87.08% | -116.67% | 255.56% | 733.33% | 597.62% |
| Cash from Investing | 21.93% | 60.47% | -7.17% | 92.33% | -134.25% |
| Total Debt Issued | -125.00% | -- | -- | -72.02% | -- |
| Total Debt Repaid | 86.13% | -400.25% | -12.13% | 40.76% | -221.18% |
| Issuance of Common Stock | 380.00% | -5.97% | -50.00% | -55.91% | -67.74% |
| Repurchase of Common Stock | 99.16% | 76.47% | -33.33% | 27.42% | -11,833.33% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.78% | -5.82% | -5.82% | -5.52% | -4.80% |
| Other Financing Activities | -200.00% | 15.63% | -- | 114.67% | 101.75% |
| Cash from Financing | 39.28% | -49.41% | 55.55% | -111.63% | -54.21% |
| Foreign Exchange rate Adjustments | 123.91% | -200.00% | 433.33% | 150.00% | -300.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 76.92% | 85.73% | 126.17% | -106.64% | -266.38% |